Cardiac Catheterization in Children with Pulmonary Hypertensive Vascular Disease: Consensus Statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces

Citations Over TimeTop 10% of 2016 papers

Abstract

Cardiac catheterization is important in the diagnosis and risk stratification of pulmonary hypertensive vascular disease (PHVD) in children. Acute vasoreactivity testing provides key information about management, prognosis, therapeutic strategies, and efficacy. Data obtained at cardiac catheterization continue to play an important role in determining the surgical options for children with congenital heart disease and clinical evidence of increased pulmonary vascular resistance. The Pediatric and Congenital Heart Disease Task Forces of the Pulmonary Vascular Research Institute met to develop a consensus statement regarding indications for, conduct of, acute vasoreactivity testing with, and pitfalls and risks of cardiac catheterization in children with PHVD. This document contains the essentials of those discussions to provide a rationale for the hemodynamic assessment by cardiac catheterization of children with PHVD.

Related Papers

• → Diagnostic and Therapeutic Cardiac Catheterization(1989)80 cited
• → Diagnostic pediatric cardiac catheterization: Experience of a tertiary care pediatric cardiac centre(2013)8 cited
• → Transradial Cardiac Catheterization and Intervention—Observations on Its Place in the Catheterization Laboratory(2010)
• Postoperative care of 13 cases with congenital heart disease with pulmonary hypertension(2009)
• Clinical significance of nitric oxide synthase mRNA expression in patients with congenital heart disease associated with pulmonary hypertension(2006)